Frank Theobald drives the strategic evolution of microneedle technology as Corporate Vice President and Head of the MAP Program at LTS. With nearly three decades in formulation development and project leadership, he transforms complex ideas into market‑ready drug‑delivery solutions. Frank shapes LTS’s global MAP strategy, accelerates innovative development pipelines, and forges impactful collaborations with academia and industry. His work positions MAPs as a disruptive technology redefining patient‑centric delivery. Frank graduated from the University of the Saarland in Pharmacy and received his PhD in Pharmaceutical Technology from the same University in 1997.